Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A. Pfeffer, Jean‐Claude Tardif, Francesca Lawson et al.|New England Journal of Medicine|2015Cited by 2.3k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Jennifer B. Green et al.|The Lancet|2018Cited by 1.8k
Consensus Report: Definition and Interpretation of Remission in Type 2 DiabetesMatthew C. Riddle, Douglas Twenefour, William T. Cefalu et al.|Diabetes Care|2021Cited by 417